MetaCap

ABVC BioPharma (ABVC) vs Rockwell Medical (RMTI)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

Rockwell Medical (RMTI) has outperformed ABVC BioPharma (ABVC) over the past year, losing 34.6% versus a loss of 67.8%. Over five years, RMTI leads with a -88.0% price change compared with -97.3% for ABVC. ABVC BioPharma is the larger company by market cap ($23.4 million vs $23.1 million), about 1.0 times the size, while Rockwell Medical is growing revenue faster (-31.8% vs -41.9%).

Rockwell Medical converts more of its revenue into profit, with a net margin of -7.7% versus -2671.8%.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

ABVC-67.80%RMTI-34.61%
+47%-16%-79%
Nov 21, 20251 yearNov 20, 2026
ABVC-97.37%RMTI-88.98%
+20%-42%-104%
Nov 15, 20215 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

ABVC versus RMTI key metrics
MetricABVCRMTI
Share price$0.8663$5.82
Market cap$23.37M$23.12M
1-day change-1.56%-7.03%
YTD return-59.33%-29.88%
1-year return-67.80%-34.61%
5-year return-97.29%-87.98%
Forward P/E—83.14
EPS (TTM)$-0.20$-1.43
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$296.00K$69.26M
Revenue growth (YoY)-41.91%-31.76%
Net income (latest FY)$-7.91M$-5.31M
Gross margin—16.89%
Operating margin-2415.97%-6.77%
Net margin-2671.81%-7.67%
52-week high$2.87$12.90
52-week low$0.707$4.89
Distance from 52-week high-69.82%-54.88%
Analyst consensus—none
Avg. price target upside—+243.64%
Average volume81.92K25.91K
Shares outstanding26.98M3.97M
Employees16157
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

Key differences

  • RMTI has outperformed ABVC by 33.2 percentage points over the past year.
  • Rockwell Medical is more profitable, keeping -7.7 cents of every revenue dollar as net income versus -2671.8 cents for ABVC BioPharma.
  • Rockwell Medical grew revenue faster in its latest fiscal year (-31.76% vs -41.91%).

About ABVC BioPharma

ABVC stock →

ABVC BioPharma, Inc., a clinical-stage biopharmaceutical company, develops drugs and medical devices to fulfill unmet medical needs in the United States. The company is developing ABV-1501, which is in Phase II clinical trials as a combination therapy for triple negative breast cancer; ABV-1504, which has completed Phase II clinical trials for depressive disorders; ABV-1505, which is in Phase II clinical trials for adult attention deficit hyperactivity disorder; ABV-1702, which is in Phase II clinical trials to treat myelodysplastic syndromes; and ABV-1601, which is in Phase I/II clinical trials for treating depression in cancer patients.

Health Care · Biotechnology: Pharmaceutical Preparations · 16 employees

About Rockwell Medical

RMTI stock →

Rockwell Medical, Inc., together with its subsidiaries, engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. It offers citrapure citric acid concentrate, dri-sate dry acid concentrate, renalpure liquid acid concentrate, dri-sate acid concentrate mixer, renalpure acid concentrate, renalpure bicarbonate concentrate, sterilyte bicarbonate concentrate, bicarbonate cartridges, and dry acid concentrate mixer, as well as ancillary products, including 5% acetic acid, cleaner, citric acid descaler, water softener salt pellets, and other supplies used by hemodialysis providers.

Health Care · Biotechnology: Pharmaceutical Preparations · 157 employees

ABVC vs RMTI FAQ

Which is bigger, ABVC BioPharma or Rockwell Medical?

ABVC BioPharma (ABVC) is larger, with a market capitalization of $23.37M compared with $23.12M for Rockwell Medical (RMTI).

Which stock has performed better over the past year, ABVC or RMTI?

RMTI returned -34.61% over the past 12 months, compared with -67.80% for ABVC (price return, excluding dividends). Past performance does not predict future results.

Are ABVC BioPharma and Rockwell Medical in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons